Oral Immunotherapy for Food Allergy—a US Regulatory Perspective
Oral Immunotherapy for Food Allergy—a US Regulatory Perspective
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
The recent approval of Palforzia for treatment of peanut allergy by the US Food and Drug Administration (USFDA) predicts that additional products for oral immunotherapy (OIT) are on the horizon. In this article, the authors review the legal framework by which the USFDA regulates products for OIT of food allergy and the clinical data that demonstrat...
Alternative Titles
Full title
Oral Immunotherapy for Food Allergy—a US Regulatory Perspective
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2451853241
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2451853241
Other Identifiers
ISSN
1529-7322
E-ISSN
1534-6315
DOI
10.1007/s11882-020-00973-x
